Gene · 7168
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic Profiling of Non-Muscle Invasive Bladder Cancer Reveals Potential Biomarkers for Recurrence and Progression Risk. | J Proteome Res | 2026 | 41587934 | PubTator, text mining | PubMed |
| Chinese medicine and intermittent fasting integration therapy attenuate diabetic vascular calcification via miR21-5p/Tpm1-mediated osteogenic differentiation of VSMCs. | Acta Pharm Sin B | 2026 | 41584359 | PubTator, text mining | PubMed |
| Early Onset Heart Failure due to RBM20 Variant: A Case Report Emphasizing Genetic Diagnosis and Arrhythmic Risk Stratification. | Clin Case Rep | 2026 | 41567528 | PubTator, text mining | PubMed |
| Sarcomeric remodelling in human heart failure unraveled by single molecule long read sequencing. | EMBO Mol Med | 2026 | 41530494 | PubTator, text mining | PubMed |
| Quantitative proteomics analysis to identify potential biomarkers associated with promoted quality profiles of frankfurters by ultrasound treatment combined with κ-carrageenan. | Food Chem | 2026 | 41265093 | PubTator, text mining | PubMed |
| Tropomyosin-1 positively regulates TGF-β/Smad3 signaling through STUB1 in arecoline-induced oral submucosal fibrosis. | Odontology | 2026 | 41203971 | PubTator, text mining | PubMed |
| Identification of Selected Genes Associated With the Prediction of Prognosis in Bladder Cancer. | Comb Chem High Throughput Screen | 2026 | 40370233 | PubTator, text mining | PubMed |
| Exploring the Therapeutic Potential of TROP2 Gene Silencing in Hepatocellular Carcinoma. | Recent Pat Biotechnol | 2026 | 39835546 | PubTator, text mining | PubMed |
| Overview of exosomal non-coding RNAs in cardiovascular disease using high throughput sequencing. | Eur J Pharmacol | 2025 | 42640698 | PubTator, text mining | PubMed |
| Evaluating Pathogenicity of TPM1 Variants of Unknown Significance Using In-silico and In-vitro Models. | J Precis Med (Amst) | 2025 | 42238220 | PubTator, text mining | PubMed |
| TPM1-p.E181K mutation suppresses CaMKII/HDAC4 signaling pathway leading to pediatric restrictive cardiomyopathy. | Front Genet | 2025 | 41568329 | PubTator, text mining | PubMed |
| Genetic Spectrum, Clinical Characteristics, and Molecular Pathogenesis of Hypertrophic Cardiomyopathy Requiring Heart Transplantation. | J Cardiovasc Dev Dis | 2025 | 41440877 | PubTator, text mining | PubMed |
| A single-cell atlas of RNA alternative splicing in the glioma-immune ecosystem. | Genome Biol | 2025 | 41387900 | PubTator, text mining | PubMed |
| Reclassification of VUS Using ACMG/AMP Criteria Adapted for Sarcomeric Genes Related to Hypertrophic Cardiomyopathy: Resolution Rate and Considerations. | Hum Mutat | 2025 | 41357762 | PubTator, text mining | PubMed |
| A bioinformatic survey of RNA isoform diversity and expression across 9 GTEx tissues using long-read sequencing data. | BMC Genomics | 2025 | 41345545 | PubTator, text mining | PubMed |
| Role of microRNA-183 based theranostics through targeting TPM1 in bladder cancer. | Discov Oncol | 2025 | 41231336 | PubTator, text mining | PubMed |
| NGS Approaches in Clinical Diagnostics: From Workflow to Disease-Specific Applications. | Int J Mol Sci | 2025 | 41096862 | PubTator, text mining | PubMed |
| Effect of Non-Muscle Tropomyosin Isoforms Encoded by the TPM1 Gene on Cofilin-1 Activity toward Actin Filaments. | Biochemistry (Mosc) | 2025 | 41067737 | PubTator, text mining | PubMed |
| Composition of cardiac-derived extracellular vesicles changes with vesicle origin and determines uptake. | Front Cardiovasc Med | 2025 | 41030476 | PubTator, text mining | PubMed |
| The influence of genotype on the phenotype and prognosis of patients with hypertrophic cardiomyopathy. | Int J Cardiovasc Imaging | 2025 | 40962998 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7168/papers?page=3